Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...

Disorders of the Male Reproductive System

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A large comprehensive comparison of large language models on ophthalmology board exams.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2026

Same author

High-normal QT interval as a predictor of 1-year mortality in hospitalized older adults.

Zeitschrift fur Gerontologie und Geriatrie·2026

Same author

Corrigendum to "The Natural History of Exophria Progression Among Young Healthy Adults". Am J Ophthalmol. 2026;282:113-119.

American journal of ophthalmology·2026

Same author

Quantifying Orbital Segmentation in Thyroid Eye Disease- Fat to Muscle Ratio Correlates With Restrictive Strabismus.

American journal of ophthalmology·2026

Same author

Cannabis, Religion, and Trust in the Medical Profession: A Cross-Religious Study of Patients' Attitudes Toward Medical and Recreational Use in Northern Israel.

Nursing inquiry·2026

Same author

Long-Term Impact of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Replacement in Patients With Small Aortic Annuli.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026

Search research articles

Related Experiment Video

Updated: Jul 7, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

Pure hypertriglyceridemia might be associated with erectile dysfunction: a pilot study.

Rafi Heruti¹, Yaron Arbel², Arie Steinvil³

¹Sexual Rehabilitation Clinic, Reuth Medical Center, Tel-Aviv, Israel;; Israel Defense Force, Medical Corps, Israel;; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel;.

The Journal of Sexual Medicine

|February 13, 2008

Summary

Erectile dysfunction (ED) prevalence may be higher in young men with severe hypertriglyceridemia. Further research is needed to confirm if high triglycerides are an independent risk factor for ED.

Related Experiment Videos

Last Updated: Jul 7, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

Area of Science:

Cardiology
Andrology
Metabolic Health

Background:

The link between erectile dysfunction (ED) and hypertriglyceridemia is not well-established, unlike the known association with high low-density lipoprotein (LDL) cholesterol.
This study investigates the prevalence and severity of ED in young men presenting with very high triglyceride levels.

Purpose of the Study:

To determine the prevalence and severity of erectile dysfunction (ED) in young men with very high triglyceride levels.
To compare ED prevalence in men with severe hypertriglyceridemia versus severe hyperlipidemia and normal lipid profiles.

Main Methods:

Eighty-eight men were analyzed, categorized into groups with severe hypertriglyceridemia, severe hyperlipidemia, or normal cholesterol levels.
Participants underwent lipid profiling and completed the Sexual Health Inventory for Men (SHIM) questionnaire.
Exclusion criteria included diabetes, ischemic heart disease, and specific HDL cholesterol levels.

Main Results:

The prevalence of ED was higher in the severe hypertriglyceridemia group (42.9%) compared to the severe hyperlipidemia (29.4%) and normal cholesterol (24.2%) groups.
These differences in ED prevalence were not statistically significant.
No significant differences in mean age or mean SHIM scores were observed between the groups.

Conclusions:

The study suggests a potential increase in ED prevalence among young men with severe hypertriglyceridemia.
Larger cohort studies with longitudinal follow-up are required to establish hypertriglyceridemia as an independent risk factor for ED.